Alpha IVF Group Bhd (XKLS:0303) EBIT: RM77.6 Mil (TTM As of Feb. 2026)


XKLS:0303 Alpha IVF Group Bhd XKLS:0303
50 GF Score
Price RM0.25
View Full Analysis

What is Alpha IVF Group Bhd EBIT?

Alpha IVF Group Bhd XKLS:0303 +2.08% 50 EBIT is RM77.6 Mil as of Feb. 2026. GuruFocus rates XKLS:0303 with a GF Score™ of 50/100.

Alpha IVF Group Bhd's earnings before interest and taxes (EBIT) for the three months ended in Feb. 2026 was RM17.5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Feb. 2026 was RM77.6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Alpha IVF Group Bhd's annualized ROC % for the quarter that ended in Feb. 2026 was 45.66%. Alpha IVF Group Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was 117.16%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Alpha IVF Group Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was 7.17%.

Alpha IVF Group Bhd  (XKLS:0303) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Alpha IVF Group Bhd's annualized ROC % for the quarter that ended in Feb. 2026 is calculated as:

ROC % (Q: Feb. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Nov. 2025 ) + Invested Capital (Q: Feb. 2026 ))/ count )
=71.656 * ( 1 - 28.39% )/( (104.574 + 120.174)/ 2 )
=51.3128616/112.374
=45.66 %

where

Invested Capital(Q: Nov. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=260.636 - 18.388 - ( 137.674 - max(0, 29.861 - 168.075+137.674))
=104.574

Invested Capital(Q: Feb. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=272.592 - 39.819 - ( 143.411 - max(0, 50.768 - 163.367+143.411))
=120.174

Note: The Operating Income data used here is four times the quarterly (Feb. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Alpha IVF Group Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Feb. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2025  Q: Feb. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=70.068/( ( (51.452 + max(-20.934, 0)) + (68.16 + max(-42.007, 0)) )/ 2 )
=70.068/( ( 51.452 + 68.16 )/ 2 )
=70.068/59.806
=117.16 %

where Working Capital is:

Working Capital(Q: Nov. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.765 + 4.056 + 0.097999999999985) - (18.388 + 0 + 8.465)
=-20.934

Working Capital(Q: Feb. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.766 + 3.957 + 0.10499999999999) - (39.819 + 0 + 8.016)
=-42.007

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Feb. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Alpha IVF Group Bhd's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Feb. 2026 )
=77.57/1082.584
=7.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha IVF Group Bhd EBIT Related Terms

Alpha IVF Group Bhd EBIT Historical Data

* Premium members only.

The historical data trend for Alpha IVF Group Bhd's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha IVF Group Bhd EBIT Chart

Alpha IVF Group Bhd Annual Data
Trend May20 May21 May22 May23 May24 May25
EBIT
Get a 7-Day Free Trial 6.23 31.28 68.24 72.82 77.03

Alpha IVF Group Bhd Quarterly Data
May20 May21 May22 May23 Oct23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.80 21.76 21.40 16.90 17.52

XKLS:0303 vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Alpha IVF Group Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpha IVF Group Bhd EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alpha IVF Group Bhd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Alpha IVF Group Bhd's EV-to-EBIT falls into.


XKLS:0303
50GF Score
Alpha IVF Group Bhd XKLS:0303
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha IVF Group Bhd EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM77.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of RM77.6 Mil mean?
Alpha IVF Group Bhd (XKLS:0303) has a EBIT of RM77.6 Mil as of Feb. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Alpha IVF Group Bhd.
Is Alpha IVF Group Bhd's EBIT too high?
Alpha IVF Group Bhd's current EBIT is RM77.6 Mil. Overall, Alpha IVF Group Bhd has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Alpha IVF Group Bhd's EBIT compare to HCA and THC?
Alpha IVF Group Bhd's EBIT of RM77.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Alpha IVF Group Bhd. Alpha IVF Group Bhd's current EBIT is RM77.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha IVF Group Bhd stock overvalued right now?
Alpha IVF Group Bhd (XKLS:0303) has a current EBIT of RM77.6 Mil. The current EBIT is RM77.6 Mil. Alpha IVF Group Bhd's overall GF Score™ is 50/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Alpha IVF Group Bhd (XKLS:0303), the current EBIT is RM77.6 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha IVF Group Bhd Business Description

Address Jalan PJU 5/22, G01, Ground Floor, Encorp Strand Mall, Kota Damansara, Darul Ehsan, Petaling Jaya, SGR, MYS, 47810
Alpha IVF Group Bhd is a fertility care specialist focusing on assisted reproductive services in Malaysia, Singapore, Indonesia, and China, with the majority of its revenue coming from Malaysia. Assisted reproductive services is a general term that includes all types of fertility treatments and procedures to help people facing difficulties in getting pregnant. The company offers a range of assisted reproductive services such as IVF to assist patients with infertility conditions in achieving clinical pregnancy. It also provides other procedures including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), various diagnostic, testing, and screening procedures, as well as cryopreservation of eggs, sperm, and embryos.
50GF Score

Get the complete analysis for XKLS:0303

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.25
Price